Why the study?
Does the presence of sarcomeric protein mutations associate with specific clinical features in patients with hypertrophic cardiomyopathy?
Does the presence of sarcomeric protein mutations associate with specific clinical features in patients with hypertrophic cardiomyopathy?
Current evidence is too heterogeneous to establish precise genotype-phenotype relationships for sarcomeric mutations in hypertrophic cardiomyopathy, highlighting the need for larger standardized studies.
Answers are grounded in this paper and cite their sources.
Avoid relying on sarcomeric genotypes to predict HCM phenotypes; leaves open precise relationships pending standardized studies.
The presence of a mutation in any sarcomere gene is associated with a number of clinical features. The heterogeneous nature of the disease and the inconsistency of study design precludes the establishment of more precise genotype-phenotype relationships. Large scale studies examining the relation between genotype, disease severity, and prognosis are required.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: